Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma

Published:2018-02-28 Issue:6 Volume:97 Page:622-626
ISSN:0022-0345
Container-title:Journal of Dental Research
language:en
Short-container-title:J Dent Res

Author:

Moskovitz J.M.¹,Ferris R.L.²

Affiliation:

1. Department of Otolaryngology, University of Pittsburgh, Pittsburgh, PA, USA

2. UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Abstract

The immune system plays an important role in the evolution of malignancy and has become an important target for novel antineoplastic agents. This review article focuses on key features of tumor immunology, including the role of immunotherapy in general and as it pertains to head and neck squamous cell carcinoma. Side effects, resistance mechanisms, and therapeutic monitoring strategies pertaining to immunotherapy are discussed.

Publisher

SAGE Publications

Subject

General Dentistry

Link

http://journals.sagepub.com/doi/pdf/10.1177/0022034518759464

Reference47 articles.

1. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting

2. Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

3. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

4. Peptide-based vaccines for cancer immunotherapy

5. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability;International Journal of Molecular Sciences;2023-07-25

2. PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors’ Response and Survival in Advanced Melanoma Patients in Brazil;Diagnostics;2023-03-09

3. A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma;Frontiers in Immunology;2022-09-23

4. Preoperative Immunotherapy in the Multidisciplinary Management of Oral Cavity Cancer;Frontiers in Oncology;2021-07-01

5. CMTM4 regulates epithelial–mesenchymal transition and PD‐L1 expression in head and neck squamous cell carcinoma;Molecular Carcinogenesis;2021-06